择优关爱医疗
OPCH
31.20
-0.02
-0.06%
择优关爱医疗
US · OPCH
#2386 按市值排名
上市于 1970
31.20
-0.02
-0.06%
实时 - 追踪5344个代码 - 心跳于228秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了1家。
- 机构持股总比例下降了1.3个百分点。
机构持股
- 机构持股比例
- 48.34% -1.27pp
- 机构数量
- 103 -1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund45.15%
Insurance Company1.70%
Individual/Insider1.39%
Sovereign Wealth Fund1.31%
Hedge Fund0.11%
Other50.28%
主要股东 截至 2026-03-31
Wellington Management Group
7.94% · 11.90M 股
Vanguard Capital Management, LLC
5.42% · 8.12M 股
Vanguard Portfolio Management, LLC
5.38% · 8.06M 股
Fuller & Thaler Asset Management, Inc.
4.76% · 7.13M 股
State Street Global Advisors
3.92% · 5.87M 股
Geode Capital Management, LLC
2.84% · 4.25M 股
Dimensional Fund Advisors
2.59% · 3.88M 股
Charles Schwab Investment Management
1.66% · 2.49M 股
Boston Partners Global Investors, Inc.
1.62% · 2.43M 股
Norges Bank Investment Management
1.31% · 1.96M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 27次买入 · 23次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| John Rademacher | Chief Executive Officer | 0.46% |
| Harry M. Kraemer | Independent Non Executive Chairman of the Board | 0.30% |
| Michael Shapiro | Chief Financial Officer | 0.18% |
| Luke Whitworth | Chief Operating Officer | 0.07% |
| David Golding | Independent Director | 0.07% |
| Meenal Sethna | Chief Financial Officer | 0.07% |
| Timothy Sullivan | Independent Director | 0.06% |
| John Arlotta | Independent Director | 0.04% |
| Collin Smyser | General Counsel | 0.03% |
| Nicole Maggio | Principal Accounting Officer | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-07-05 | Prateek Bhatia | -- | Other Acquisition | +39,795 | -- |
| 2026-05-19 | Timothy Sullivan | Independent Director | Other Acquisition | +13,833 | $22.23 |
| 2026-05-19 | Eric Brandt | Director | Other Acquisition | +11,640 | $22.23 |
| 2026-05-19 | Harry M. Kraemer | Independent Non Executive Chairman of the Board | Other Acquisition | +8,997 | -- |
| 2026-05-19 | Harry M. Kraemer | Independent Non Executive Chairman of the Board | Other Acquisition | +12,079 | $22.23 |
| 2026-05-19 | R. Pate | Independent Director | Other Acquisition | +8,997 | -- |
| 2026-05-19 | Elizabeth Bierbower | Independent Director | Other Acquisition | +8,997 | -- |
| 2026-05-19 | Barbara Bodem | Director | Other Acquisition | +8,997 | -- |
| 2026-05-19 | Norman Wright | Director | Other Acquisition | +8,997 | -- |
| 2026-05-19 | Natasha Deckmann | Independent Director | Other Acquisition | +9,841 | $22.23 |
| 2026-05-18 | Collin Smyser | General Counsel | Derivative Exercise and Sale | -360 | $20.86 |
| 2026-05-18 | Collin Smyser | General Counsel | Derivative Exercise and Retained | +452 | -- |
| 2026-05-06 | Timothy Sullivan | Independent Director | Open Market Acquisition | +24,154 | $20.69 |
| 2026-05-03 | Harry M. Kraemer | Independent Non Executive Chairman of the Board | Open Market Acquisition | +36,610 | $21.41 |
| 2026-05-03 | John Rademacher | Chief Executive Officer | Open Market Acquisition | +12,500 | $21.18 |
| 2026-05-03 | Meenal Sethna | Chief Financial Officer | Open Market Acquisition | +16,225 | $20.16 |
| 2026-04-21 | Femi Adewunmi | Chief Medical Officer | Sale to Issuer | -1,396 | $28.38 |
| 2026-02-26 | R. Pate | Independent Director | Open Market Disposition | -30,287 | $32.05 |
| 2026-02-26 | Michael Bavaro | Chief Human Resources & Diversity Officer | Open Market Disposition | -6,000 | $33.00 |
| 2026-02-25 | R. Pate | Independent Director | Intent to Sell (Form 144) | -30,287 | $31.89 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:23 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
择优关爱医疗 讨论区 0 条评论